Abbott Molecular, a genomic disease management company, engages in the development and marketing of clinical laboratory products, which provide information critical to the evaluation and management of cancer, prenatal disorders, and other genetic diseases. The Company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies.
Company Growth (employees)
Illinois City, US
Size (employees)
75,000 (est)
Abbott was founded in 1991 and is headquartered in Illinois City, US

Key People/Management at Abbott

Miles White

Miles White

Stephen Fussell

Stephen Fussell

Executive Vice President, Human Resources

Abbott Office Locations

Abbott has offices in Illinois City, Sao Paulo, Shanghai, Beijing and in 5 other locations
Sao Paulo, BR
Rua Michigan, 735 – Brooklin
Beijing, CN
17F, Canway Builing, No. 66 Nanlishi Road
Shanghai, CN
23F/26F/27F/28F/32F/33F/36F/37F/39F, Ciro’s Plaza, No. 388 West Nanjing Road
Wiesbaden, DE
Abbott GmbH & Co. KG, Max-Planck-Ring 2
Tokyo, JP
3-5-27, Mita, Minato-ku
Seoul, KR
Samtan Bldg., 3rd Floor, 421 YoungDong-Daero, Kangnam-Ku
Show all (9)

Abbott Financials and Metrics

Abbott Financials

Abbott's revenue was reported to be $20.9 b in FY, 2016

Revenue (Q2, 2017)

6.6 b

Gross profit (Q2, 2017)

3.5 b

Gross profit margin (Q2, 2017), %


Net income (Q2, 2017)

283 m

EBIT (Q2, 2017)

427 m

Market capitalization (13-Dec-2017)

96.6 b

Cash (30-Jun-2017)

9.7 b


110.9 b
Abbott's current market capitalization is $96.6 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


21.8 b20.2 b20.4 b20.9 b

Revenue growth, %


Cost of goods sold

10 b9.2 b8.7 b9 b

Gross profit

11.8 b11 b11.7 b11.8 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


5.4 b5.2 b5.6 b5.1 b4.9 b5.2 b5.2 b4.9 b5.3 b5.3 b6.3 b6.6 b

Cost of goods sold

2.5 b2.5 b2.5 b2.3 b2.1 b2.2 b2.2 b2.1 b2.3 b2.3 b3 b3.2 b

Gross profit

2.9 b2.8 b3 b2.8 b2.8 b3 b2.9 b2.7 b3 b3 b3.3 b3.5 b

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


3.5 b4.1 b5 b18.6 b

Accounts Receivable

4 b3.6 b3.4 b3.2 b


2.7 b2.6 b2.6 b2.4 b

Current Assets

19.2 b15.3 b14.2 b26.8 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


2.9 b2.1 b3.6 b3.6 b3.2 b4 b3.1 b3.3 b2.6 b2.5 b8.7 b9.7 b


2.8 b2.8 b2.8 b2.7 b2.6 b2.7 b2.6 b2.8 b2.8 b2.6 b4 b3.6 b

Current Assets

19.7 b17.9 b18.3 b16.5 b20 b21.1 b15.9 b12.4 b13 b13 b19.3 b20 b


9.7 b9.8 b9.8 b10 b9.9 b9.9 b9.8 b9.8 b9.8 b7.8 b21.4 b22.1 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2.6 b2.3 b4.4 b1.4 b

Accounts Receivable

113 m195 m171 m177 m


(154 m)(297 m)(257 m)(98 m)

Accounts Payable

256 m225 m742 m652 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

965.7 m375 m466 m538 m2.3 b3.1 b3.7 b316 m931 m602 m419 m702 m

Depreciation and Amortization

723 m1.1 b347 m694 m1 b774 m1.4 b


(210 m)(213 m)(95 m)(149 m)(152 m)(162 m)(127 m)

Cash From Operating Activities

943 m2.1 b816 m2 b1.9 b
USDY, 2017


259.8 x


57.6 x


88.5 k
Show all financial metrics

Abbott Operating Metrics

FY, 2014FY, 2015FY, 2016


10 k1.5 k1.5 k

New Product Launches

Show all operating metrics

Abbott Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
AlereAugust 14, 2017$5.3 b
St. Jude MedicalApril 28, 2016$25 b
Kalila MedicalApril 06, 2016

Abbott Market Value History

Abbott's Web-traffic and Trends

Abbott Online and Social Media Presence

Abbott Company Life and Culture

You may also be interested in